Contrast-enhanced MR angiography of the renal arteries: Blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine

Radiology

Volumn 234, Issue 2, 2005, Pages 399-408

  Prokop, Mathias ^a   Schneider, Günther ^b   Vanzuili, Angelo ^c   Goyen, Mathias ^d   Ruehm, Stefan G ^d   Douek, Philippe ^e   Daprà, Massimo ^f   Pirovano, Gianpaolo ^g   Kirchin, Miles A ^f   Spinazzi, Alberto ^f,g  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b SAARLAND UNIVERSITY   (Germany)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e LOUIS PRADEL HOSPITAL   (France)

^f Worldwide Medical Affairs   (Italy)

^g Worldwide Medical Affairs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE MEGLUMINE;

ABDOMINAL AORTA; ADULT; AGED; ARTHRALGIA; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC ACCURACY; DYSURIA; FAT EMBOLISM; FEMALE; HEADACHE; HUMAN; HYPERTENSION; INFORMED CONSENT; KIDNEY PAIN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RENAL ARTERY; RISK ASSESSMENT; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; CROSS-OVER STUDIES; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; RENAL ARTERY;

EID: 19944433022     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2342040023     Document Type: Article

References (40)

1. Prince MR, Narasimham DL, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995; 197:785-792.
2. Holland GA, Dougherty L, Carpenter JP, et al. Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries. AJR Am J Roentgenol 1996; 166:971-981.
3. Steffens JC, Link J, Grassner J, et al. Contrast-enhanced, K-space-centered, breath-hold MR angiography of the renal arteries and the abdominal aorta. J Magn Reson Imaging 1997; 7:617-622.
4. Hany TF, Debatin JF, Leung DA, Pfammatter T. Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 1997; 204:357-362.
5. De Cobelli F, Vanzulli A, Sironi S, et al. Renal artery stenosis: evaluation with breath-hold, three-dimensional, dynamic, gadolinium-enhanced versus three-dimensional, phase-contrast MR angiography. Radiology 1997; 205:689-695.
6. Bakker J, Beek FJ, Beutler JJ, et al. Renal artery stenosis and accessory renal arteries: accuracy of detection and visualization with gadolinium-enhanced breath-hold MR angiography. Radiology 1998; 207:497-504.
7. Schoenberg SO, Bock M, Knopp MV, et al. Renal arteries: optimization of three-dimensional gadolinium-enhanced MR angiography with bolus-timing- independent fast multiphase acquisition in a single breath hold. Radiology 1999; 211: 667-679.
8. Thornton MJ, Thornton F, O'Callaghan J, et al. Evaluation of dynamic gadolinium-enhanced breath-hold MR angiography in the diagnosis of renal artery stenosis. AJR Am J Roentgenol 1999; 173:1279-1283.
9. Shetty AN, Bis KG, Kirsch M, Weintraub J, Laub G. Contrast-enhanced breath-hold three-dimensional magnetic resonance angiography in the evaluation of renal arteries: optimization of technique and pitfalls. J Magn Reson Imaging 2000; 12: 912-923.
10. Bongers V, Bakker J, Beutler JJ, Beek FJ, De Klerk JM. Assessment of renal artery stenosis: comparison of captopril renography and gadolinium-enhanced breath-hold MR angiography. Clin Radiol 2000; 55:346-353.
11. Mittal TK, Evans C, Perkins T, Wood AM. Renal arteriography using gadolinium enhanced 3D MR angiography: clinical experience with the technique, its limitations and pitfalls. Br J Radiol 2001; 74: 495-502.
12. Fain SB, King BF, Breen JF, Kruger DG, Riederer SJ. High-spatial- resolution contrast-enhanced MR angiography of the renal arteries: a prospective comparison with digital subtraction angiography. Radiology 2001; 218:481-490.
13. Masunaga H, Takehara Y, Isoda H, et al. Assessment of gadolinium-enhanced time-resolved three-dimensional MR angiography for evaluating renal artery stenosis. AJR Am J Roentgenol 2001; 176: 1213-1219.
14. Mallouhi A, Schocke M, Judmaier W, et al. 3D MR angiography of renal arteries: comparison of volume rendering and maximum intensity projection algorithms. Radiology 2002; 223:509-516.
15. Many TF, Schmidt M, Hunker PR, Steiner P, Bachmann U, Debatin JF. Optimization of contrast dosage for gadolinium-enhanced 3D MRA of the pulmonary and renal arteries. Magn Reson Imaging 1998; 16:901-906.
16. Dong Q, Schoenberg SO, Carlos RC, et al. Diagnosis of renal vascular disease with MR angiography. RadioGraphics 1999; 19:1535-1554.
17. Leung DA, Hagspiel KD, Angle JF, Spinosa DJ, Matsumoto AH, Butty S. MR angiography of the renal arteries. Radiol Clin North Am 2002; 40:847-865.
18. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins: a new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997; 32:780-796.
19. de Haën C, Cabrini M, Akhnana L, et al. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance): pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 1999; 23(suppl 1):S161-S168.
20. Knopp MV, Schoenberg SO, Rehm C, et al. Assessment of gadobenate dimeglumine (Gd-BOFTA) for MR angiography: phase I studies. Invest Radiol 2002; 37: 706-715.
21. Knopp MV, Giesel FL, von Tengg-Kobligk H, et al. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglurnine. J Magn Reson Imaging 2003; 17:694-702.
22. Völk M, Strotzer M, Lenhart M, et al. Renal time-resolved MR angiography: quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses. Radiology 2001; 220:484-488.
23. Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol 1979; 8:7-20.
24. Armitage P, Hill M. The two-period cross-over trial. Statistician 1982; 31:119-131.
25. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York, NY: Wiley, 1981.
26. Qanadli SD, Soulez G, Therasse E, et al. Detection of renal artery stenosis: prospective comparison of captopril-enhanced Doppler sonography, captopril-enhanced scintigraphy, and MR angiography. AJR Am J Roentgenol 2001; 177:1123-1129.
27. De Cobelli F, Venturini M, Vanzulli A, et al. Renal artery stenosis: prospective comparison of color Doppler US and breath-hold, three-dimensional, dynamic, gadolinium-enhanced MR angiography. Radiology 2000; 214:373-380.
28. Gilfeather M, Yoon H-C, Siegelman ES, et al. Renal artery stenosis: evaluation with conventional angiography versus gadolinium-enhanced MR angiography. Radiology 1999; 210:367-372.
29. Völk M, Strotzer M, Lenhart M, et al. Time-resolved contrast-enhanced MR angiography of renal artery stenosis: diagnostic accuracy and interobserver variability. AJR Am J Roentgenol 2000; 174: 1583-1588.
30. Korst MB, Joosten FB, Postma CT, Jager GJ, Krabbe JK, Barentsz JO. Accuracy of normal-dose contrast-enhanced MR angiography in assessing renal artery stenosis and accessory renal arteries. AJR Am J Roentgenol 2000; 174:629-634.
31. Willmann JK, Wildermuth S, Pfammatter T, et al. Aortoiliac and renal arteries: prospective intraindividual comparison of contrast-enhanced three-dimensional MR angiography and multi-detector row CT angiography. Radiology 2003; 226:798-811.
32. Rankin SC, Jan W, Koffman CG. Noninvasive imaging of living related kidney donors: evaluation with CT angiography and gadolinium-enhanced MR angiography. AJR Am J Roentgenol 2001; 177: 349-355.
33. Tombach B, Bremer C, Reimer P, et al. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Radiology 2001; 218:651-657.
34. Herborn C, Lauenstein T, Ruehm S, Bosk S, Debatin J, Goyen M. Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine and gadobutrol for pelvic 3D magnetic resonance angiography. Invest Radiol 2003; 38:27-33.
35. Wyttenbach R, Gianella S, Alerci M, Braghetti A, Cozzi L, Gallino A. Prospective blinded evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography. Radiology 2003; 227: 261-269.
36. Janzen J, Lanzer P, Rothenberger-Janzen K, Vuong PN. The transitional zone in the tunica media of renal arteries has a maximal length of 10 millimetres. Vasa 2000; 29:168-172.
37. Schuhmann-Giampieri G, Krestin G. Pharmacokinetics of Gd-DTPA in patients with chronic renal failure. Invest Radiol 1991; 26:975-979.
38. Swan SK, Lambrecht LJ, Townsend R, et al. Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment. Invest Radiol 1999; 34:443-448.
39. Kroencke TJ, Wasser MN, Pattynama PM, et al. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the abdominal aorta and renal arteries. AJR Am J Roentgenol 2002; 179:1573-1582.
40. Wikström J, Wasser MN, Pattynama PM, et al. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the pelvic arteries. Invest Radiol 2003; 38:504-515.